Matches in SemOpenAlex for { <https://semopenalex.org/work/W2074134911> ?p ?o ?g. }
- W2074134911 endingPage "408" @default.
- W2074134911 startingPage "397" @default.
- W2074134911 abstract "Objectives Novel quantitative proteomic approaches were used to study the effects of inhibition of glycogen phosphorylase on proteome and signaling pathways in MIA PaCa-2 pancreatic cancer cells. Methods We performed quantitative proteomic analysis in MIA PaCa-2 cancer cells treated with a stratified dose of CP-320626 (5-chloro-1H-indole-2-carboxylic acid [1-(4-fuorobenzyl)-2-(4-hydroxypiperidin-1-yl)-2 oxoethyl] amide) (25, 50, and 100 μM). The effect of metabolic inhibition on cellular protein turnover dynamics was also studied using the modified SILAC (stable isotope labeling with amino acids in cell culture) method. Results A total of 22 protein spots and 4 phosphoprotein spots were quantitatively analyzed. We found that dynamic expression of total proteins and phosphoproteins was significantly changed in MIA PaCa-2 cells treated with an incremental dose of CP-320626. Functional analyses suggested that most of the proteins differentially expressed were in the pathways of mitogen-activated protein kinase/extracellular signal–regulated kinase and tumor necrosis factor α/nuclear factor κB. Conclusions Signaling pathways and metabolic pathways share many common cofactors and substrates forming an extended metabolic network. The restriction of substrate through 1 pathway such as inhibition of glycogen phosphorylation induces pervasive metabolomic and proteomic changes manifested in protein synthesis, breakdown, and posttranslational modification of signaling molecules. Our results suggest that quantitative proteomic is an important approach to understand the interaction between metabolism and signaling pathways. Abbreviations MALDI - matrix-assisted laser desorption ionization, TOF/TOF MS - time-of-flight/time-of-flight mass spectrometry, 2-DE - 2-dimensional electrophoresis, PMF - peptide mass fingerprinting, CP-320626 - 5-chloro-1H-indole-2-carboxylic acid [1-(4-fuorobenzyl)-2-(4-hydroxypiperidin-1-yl)-2 oxoethyl]amide" @default.
- W2074134911 created "2016-06-24" @default.
- W2074134911 creator A5007947547 @default.
- W2074134911 creator A5008524910 @default.
- W2074134911 creator A5019619940 @default.
- W2074134911 creator A5040985629 @default.
- W2074134911 creator A5042963506 @default.
- W2074134911 creator A5052478195 @default.
- W2074134911 creator A5056302674 @default.
- W2074134911 creator A5067881411 @default.
- W2074134911 creator A5078996176 @default.
- W2074134911 date "2012-04-01" @default.
- W2074134911 modified "2023-09-28" @default.
- W2074134911 title "Inhibition of Glycogen Phosphorylation Induces Changes in Cellular Proteome and Signaling Pathways in MIA Pancreatic Cancer Cells" @default.
- W2074134911 cites W1611935912 @default.
- W2074134911 cites W1804584144 @default.
- W2074134911 cites W1966099909 @default.
- W2074134911 cites W1969436325 @default.
- W2074134911 cites W1975854213 @default.
- W2074134911 cites W1976632546 @default.
- W2074134911 cites W1987611065 @default.
- W2074134911 cites W1987785670 @default.
- W2074134911 cites W1990560133 @default.
- W2074134911 cites W1991429659 @default.
- W2074134911 cites W2006294797 @default.
- W2074134911 cites W2007980905 @default.
- W2074134911 cites W2016071270 @default.
- W2074134911 cites W2017641016 @default.
- W2074134911 cites W2029675948 @default.
- W2074134911 cites W2039262653 @default.
- W2074134911 cites W2047806545 @default.
- W2074134911 cites W2052561585 @default.
- W2074134911 cites W2055444005 @default.
- W2074134911 cites W2058218780 @default.
- W2074134911 cites W2060767516 @default.
- W2074134911 cites W2063411256 @default.
- W2074134911 cites W2064423385 @default.
- W2074134911 cites W2066299293 @default.
- W2074134911 cites W2066502841 @default.
- W2074134911 cites W2068982799 @default.
- W2074134911 cites W2072451938 @default.
- W2074134911 cites W2074114480 @default.
- W2074134911 cites W2092104789 @default.
- W2074134911 cites W2097259163 @default.
- W2074134911 cites W2098412103 @default.
- W2074134911 cites W2098440219 @default.
- W2074134911 cites W2100177180 @default.
- W2074134911 cites W2102878034 @default.
- W2074134911 cites W2111930548 @default.
- W2074134911 cites W2114918609 @default.
- W2074134911 cites W2118604693 @default.
- W2074134911 cites W2121727754 @default.
- W2074134911 cites W2136331997 @default.
- W2074134911 cites W2147489705 @default.
- W2074134911 cites W2150703531 @default.
- W2074134911 cites W2154121575 @default.
- W2074134911 cites W2160008754 @default.
- W2074134911 cites W2161128788 @default.
- W2074134911 cites W2165266462 @default.
- W2074134911 cites W2165721436 @default.
- W2074134911 cites W2896458647 @default.
- W2074134911 doi "https://doi.org/10.1097/mpa.0b013e318236f022" @default.
- W2074134911 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3306546" @default.
- W2074134911 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22158071" @default.
- W2074134911 hasPublicationYear "2012" @default.
- W2074134911 type Work @default.
- W2074134911 sameAs 2074134911 @default.
- W2074134911 citedByCount "20" @default.
- W2074134911 countsByYear W20741349112012 @default.
- W2074134911 countsByYear W20741349112014 @default.
- W2074134911 countsByYear W20741349112015 @default.
- W2074134911 countsByYear W20741349112016 @default.
- W2074134911 countsByYear W20741349112017 @default.
- W2074134911 countsByYear W20741349112019 @default.
- W2074134911 countsByYear W20741349112020 @default.
- W2074134911 countsByYear W20741349112022 @default.
- W2074134911 countsByYear W20741349112023 @default.
- W2074134911 crossrefType "journal-article" @default.
- W2074134911 hasAuthorship W2074134911A5007947547 @default.
- W2074134911 hasAuthorship W2074134911A5008524910 @default.
- W2074134911 hasAuthorship W2074134911A5019619940 @default.
- W2074134911 hasAuthorship W2074134911A5040985629 @default.
- W2074134911 hasAuthorship W2074134911A5042963506 @default.
- W2074134911 hasAuthorship W2074134911A5052478195 @default.
- W2074134911 hasAuthorship W2074134911A5056302674 @default.
- W2074134911 hasAuthorship W2074134911A5067881411 @default.
- W2074134911 hasAuthorship W2074134911A5078996176 @default.
- W2074134911 hasBestOaLocation W20741349112 @default.
- W2074134911 hasConcept C104317684 @default.
- W2074134911 hasConcept C104397665 @default.
- W2074134911 hasConcept C11960822 @default.
- W2074134911 hasConcept C150555746 @default.
- W2074134911 hasConcept C184235292 @default.
- W2074134911 hasConcept C185592680 @default.
- W2074134911 hasConcept C192989942 @default.
- W2074134911 hasConcept C34905852 @default.
- W2074134911 hasConcept C46111723 @default.
- W2074134911 hasConcept C55493867 @default.